Skip to main content
Skip to footer
About
Active Biotech in Brief
Management
Board of Directors
Goals and Strategy
Corporate Governance
Corporate Governance Report 2025
Article of Association
General Meetings
Audit committee
Scientific committee
Election Committee
Auditors
Projects
Our projects
Tasquinimod
Laquinimod
Naptumomab
Patents
Clinical Studies
Investor
Overview
Analyses and Presentations
Financial Calendar
Financial Reports
Shareholders
Events
Rights Issues
Rights Issue 2025
Media
Overview
Press Contact
Press Releases
Contact
Svenska
General Meetings
General Meetings
Annual General Meeting 2026
Extraordinary General Meeting 2025
Annual General Meeting 2025
Extraordinary General Meeting 2024
Annual General Meeting 2024
Annual General Meeting 2023
Annual General Meeting 2022
Annual General Meeting 2021
Extraordinary General Meeting 2020
Annual General Meeting 2020
